IL17A and psoriasis: (1) Established IL-17A pathway involvement in psoriasis and hidradenitis suppurativa pathogenesis (5, 6); (2) Emerging evidence of IL-17A’s potential role in colorectal cancer modulation (8–10); (3) Its IgG4 structure minimizing immunogenicity risks (23).